Insights

Clinical-stage development focus Acadia Pharmaceuticals Inc. is targeting the negative symptoms of schizophrenia, Alzheimer’s disease psychosis, and neuropsychiatric symptoms. This presents an opportunity to engage with healthcare providers and institutions looking for innovative solutions in these therapeutic areas.

Recent key hires in R&D The appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development showcases a focus on strengthening R&D capabilities. Leveraging this expertise can open doors for collaborations with research organizations seeking cutting-edge pharmaceutical advancements.

Investments from asset management groups Notable investments from asset management groups like Mutual of America Financial Group and North America Asset Management Group indicate confidence in ACADIA Pharmaceuticals Inc. This financial backing signals market validation, making it appealing for potential investors or partners looking to align with a promising pharmaceutical company.

Innovative treatment options The launch of G protein-coupled receptor GPR88 agonists for various disorders such as ADHD, substance abuse, schizophrenia, and more presents a unique selling point. This innovative treatment approach can attract partnerships with healthcare providers looking to offer diversified therapeutic options to their patients.

Acquisition of Bobsled Marketing LLC The acquisition of Bobsled Marketing LLC showcases a strategic move towards enhancing digital marketing capabilities. Sales development representatives can leverage this acquisition to explore cross-selling opportunities with healthcare companies seeking comprehensive marketing solutions in the pharmaceutical industry.

Acadia Pharmaceuticals Inc. Tech Stack

Acadia Pharmaceuticals Inc. uses 8 technology products and services including SAS/STAT, SAS, Microsoft Excel, and more. Explore Acadia Pharmaceuticals Inc.'s tech stack below.

  • SAS/STAT
    Advanced Analytics And Data Science
  • SAS
    Business Intelligence
  • Microsoft Excel
    Editors
  • ADP
    Human Resource Management System
  • Microsoft
    Miscellaneous
  • Android
    Programming Languages
  • Base SAS
    Software As A Service
  • BlueJeans
    Web Conferencing

Media & News

Acadia Pharmaceuticals Inc.'s Email Address Formats

Acadia Pharmaceuticals Inc. uses at least 2 format(s):
Acadia Pharmaceuticals Inc. Email FormatsExamplePercentage
flast@acadia-pharm.comJDoe@acadia-pharm.com
78%
first.last@acadia-pharm.comJohn.Doe@acadia-pharm.com
12%
lfirst@acadia-pharm.comDJohn@acadia-pharm.com
6%
first@acadia-pharm.comJohn@acadia-pharm.com
1%
lastfirst@acadia-pharm.comDoeJohn@acadia-pharm.com
1%
fl@acadia-pharm.comJD@acadia-pharm.com
0%
filast@acadia-pharm.comJoDoe@acadia-pharm.com
1%
f.last@acadia-pharm.comJ.Doe@acadia-pharm.com
0%
fmlast@acadia-pharm.comJMDoe@acadia-pharm.com
1%
first.l@acadia-pharm.comJohn.D@acadia-pharm.com
0%
fmiddlelast@acadia-pharm.comJMichaelDoe@acadia-pharm.com
0%
firstl@acadia-pharm.comJohnD@acadia-pharm.com
0%
first.last@acadia.comJohn.Doe@acadia.com
78%
flast@acadia.comJDoe@acadia.com
21%
firstlast@acadia.comJohnDoe@acadia.com
1%

Frequently Asked Questions

Where is Acadia Pharmaceuticals Inc.'s headquarters located?

Minus sign iconPlus sign icon
Acadia Pharmaceuticals Inc.'s main headquarters is located at 12830 El Camino Real Suite 400 San Diego, California 92130-3331 US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Acadia Pharmaceuticals Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Acadia Pharmaceuticals Inc.'s main corporate office by phone at +1-858-558-2871. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Acadia Pharmaceuticals Inc.'s stock symbol?

Minus sign iconPlus sign icon
Acadia Pharmaceuticals Inc. is a publicly traded company; the company's stock symbol is ACAD.

What is Acadia Pharmaceuticals Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Acadia Pharmaceuticals Inc.'s official website is acadia.com and has social profiles on LinkedIn.

How much revenue does Acadia Pharmaceuticals Inc. generate?

Minus sign iconPlus sign icon
As of June 2024, Acadia Pharmaceuticals Inc.'s annual revenue reached $750M.

What is Acadia Pharmaceuticals Inc.'s NAICS code?

Minus sign iconPlus sign icon
Acadia Pharmaceuticals Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Acadia Pharmaceuticals Inc. have currently?

Minus sign iconPlus sign icon
As of June 2024, Acadia Pharmaceuticals Inc. has approximately 756 employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Information Officer Cio And Chief Administrative Officer Cao: M. M. Z.Chief Accounting Officer: J. K.Chief Product Officer: F. D.. Explore Acadia Pharmaceuticals Inc.'s employee directory with LeadIQ.

What industry does Acadia Pharmaceuticals Inc. belong to?

Minus sign iconPlus sign icon
Acadia Pharmaceuticals Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Acadia Pharmaceuticals Inc. use?

Minus sign iconPlus sign icon
Acadia Pharmaceuticals Inc.'s tech stack includes SAS/STATSASMicrosoft ExcelADPMicrosoftAndroidBase SASBlueJeans.

What is Acadia Pharmaceuticals Inc.'s email format?

Minus sign iconPlus sign icon
Acadia Pharmaceuticals Inc.'s email format typically follows the pattern of . Find more Acadia Pharmaceuticals Inc. email formats with LeadIQ.

How much funding has Acadia Pharmaceuticals Inc. raised to date?

Minus sign iconPlus sign icon
As of June 2024, Acadia Pharmaceuticals Inc. has raised $288M in funding. The last funding round occurred on Sep 17, 2019.

When was Acadia Pharmaceuticals Inc. founded?

Minus sign iconPlus sign icon
Acadia Pharmaceuticals Inc. was founded in 1993.
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

Pharmaceutical ManufacturingCalifornia, United States501-1000 Employees

Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For 30 years, we have been working at the forefront of healthcare to bring vital solutions to people who need them most.

We developed and commercialized the first and only approved therapies for hallucinations and delusions associated with Parkinson’s disease psychosis and for the treatment of Rett syndrome. Our clinical-stage development efforts are focused on treating the negative symptoms of schizophrenia, Alzheimer’s disease psychosis and neuropsychiatric symptoms in central nervous system disorders.

Important Notice for Candidates - Be Aware of Fraudulent Recruiting Activity

Acadia Pharmaceuticals has become aware of fraudulent recruiting activity being circulated via email and LinkedIn by individuals impersonating Acadia Talent Acquisition employees. These communications may appear legitimate due to an official-looking Acadia email address or website, referencing of an actual recruiter and/or manager at Acadia (easily found on LinkedIn), and/or offer documents falsely signed by an Acadia executive. The impostor uses the incentive of a job interview and job offer to solicit sensitive personal information from the intended victim.

Please note that the Acadia Talent Acquisition and HR Team will ONLY interact with a candidate from "Acadia-pharm.com" domain sourced emails. We do not request sensitive personal information, such as a Social Security Number, or payments of any kind during the interview or job offer process. Acadia strongly recommends individuals, who receive email solicitations, to carefully verify the authenticity of the correspondence before responding. Never provide personal information or click on links if you are unsure a communication’s legitimacy. If in doubt, please contact talentacquisition@acadia-pharm.com to verify.

Section iconCompany Overview

Headquarters
12830 El Camino Real Suite 400 San Diego, California 92130-3331 US
Phone number
+1-858-558-2871
Website
acadia.com
Stock Symbol
ACAD
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1993
Employees
501-1000

Section iconFunding & Financials

  • $288M

    Acadia Pharmaceuticals Inc. has raised a total of $288M of funding over 14 rounds. Their latest funding round was raised on Sep 17, 2019.

  • $100M$1B

    Acadia Pharmaceuticals Inc.'s revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $288M

    Acadia Pharmaceuticals Inc. has raised a total of $288M of funding over 14 rounds. Their latest funding round was raised on Sep 17, 2019.

  • $100M$1B

    Acadia Pharmaceuticals Inc.'s revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.